The Cleveland Clinic
Also known as: Akron General Medical Center | Akron Medical Center, Akron, OH | American Center of Reproductive Medicine, Cleveland Clinic | Amy Lightner | Cleveland Clinic Akron General | Cleveland Clinic Canada | Cleveland Clinic Florida | Cleveland Clinic Florida Gynecology | Cleveland Clinic Foundation, Case Comprehensive Cancer Center | Cleveland Clinic Foundation, Cleveland OH | Cleveland Clinic Health System | CLEVELAND CLINIC LERNER COM-CWRU | Cleveland Clinic Lou Ruvo Center for Brain Health | Cleveland Clinics | Cleveland Clinic, Taussig Cancer Institute, Case Comprehensive Cancer Center | Cleveland Clinic Women's Health Institute | David Lang | Director, Cleveland Clinic's Center for Genitourinary Malignancies Research | d sessler | Edward Maytin, MD, PhD | Elaine Husni | Justis Ehlers | michael macknin | Mina Chung, MD | Mykol Larvie, MD, PhD | Nizar Zein | Reena Mehra, MD | Rishi Singh | Saad Jamshed MD | Shnehal Patel | Soumya Chatterjee | Tatiana Falcone, MD | The Cleveland Clinic | Wael Jaber
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1995Last known activity
Apr 1, 2026
Timeline
1920s
- Jun 1, 1921
The Cleveland Clinic— Founded
Drugs by trial phase (191 distinct, 185 trials)
Phase 4 (54 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (56 own, 0 via acquisition)
Phase 1 (20 own, 0 via acquisition)
Other trials (28 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Amyloidosis
- Anterior Cruciate Ligament Injuries
- Arteritis
- Arthritis, Psoriatic
- Astrocytoma
- Atrial Fibrillation
- Basal Cell Carcinoma
- Basal Cell Nevus Syndrome
- Brain Neoplasms
- Calculi
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cardiac Output, Low
- Cataract
- Chronic Disease
- Clostridium Infections
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Constipation
- Crohn Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Ketoacidosis
- Diabetic Retinopathy
- Diarrhea
- Dyspareunia
- Edema
- Emphysema
- Encephalitis
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fatty Liver
- Fatty Liver, Alcoholic
- Fistula
- Giant Cell Arteritis
- Glioblastoma
- Glioma
- Heart Diseases
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hernia
- Hernia, Ventral
- Hypersensitivity
- Hypertension
- Ileus
- Infections
- Inflammation
- Influenza, Human
- Insulin Resistance
- Keratosis
- Keratosis, Actinic
- Ketosis
- Kidney Calculi
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Diseases
- Lung Diseases, Obstructive
- Lupus Nephritis
- Lymphoma
- Lymphoma, Non-Hodgkin
- Macular Edema
- Melanoma
- Metabolic Syndrome
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Necrosis
- Neoplasms
- Neoplasms, Squamous Cell
- Nephritis
- Nephrolithiasis
- Nephrosclerosis
- Nerve Degeneration
- Obesity
- Osteoarthritis
- Osteoarthritis, Knee
- Pancreatic Diseases
- Pancreatic Neoplasms
- Pancreatitis
- Pancreatitis, Chronic
- Parkinson Disease
- Peanut Hypersensitivity
- Pelvic Floor Disorders
- Pelvic Pain
- Phantom Limb
- Plaque, Amyloid
- Pneumonia
- Polymyalgia Rheumatica
- Postoperative Nausea and Vomiting
- Postoperative Pain
Recent trials (50)
- NCT05544032Overall official - principal investigatorN/A—
- NCT07222956Lead sponsorPhase 2Apr 1, 2026
- NCT07222956Sponsor investigatorPhase 2Apr 1, 2026
- NCT07222956OfficialPhase 2Apr 1, 2026
- NCT07220382Lead sponsorPhase 4Nov 3, 2025
- NCT07222072Lead sponsorPhase 4Nov 3, 2025
- NCT07220382Sponsor investigatorPhase 4Nov 3, 2025
- NCT07220382OfficialPhase 4Nov 3, 2025
- NCT07222072OfficialPhase 4Nov 3, 2025
- NCT06868485OfficialPhase 2Aug 18, 2025
- NCT07138560Lead sponsorPhase 4Jul 24, 2025
- NCT07138560OfficialPhase 4Jul 24, 2025
- NCT07138560Sponsor investigatorPhase 4Jul 24, 2025
- NCT06973785Lead sponsorPhase 3Jul 15, 2025
- NCT06973785OfficialPhase 3Jul 15, 2025
Details
- Founded
- Cleveland, OH, US Jun 1, 1921
- Last known activity
- Apr 1, 2026